85
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

The Role of Oral Mucositis on the Systemic Inflammation Parameter IL-8 in Febrile Neutropenic Cancer Patients

, R.D.H., Ph.D., , M.D., Ph.D., , D.D.S., Ph.D., , M.D., Ph.D., , M.D., Ph.D., , M.D., Ph.D., , M.D., Ph.D., , M.D., Ph.D., , M.D., Ph.D., , M.D., Ph.D. & , M.D., Ph.D. show all
Pages 479-483 | Published online: 11 Jun 2009

REFERENCES

  • Sickles E. A., Greene W. H., Wiernik P. H. Clinical presentation of infection in granulocytopenic patients. Arch. Intern. Med. 1975; 135(5)715–719, [INFOTRIEVE], [CSA]
  • de Bont E. S.J.M., Vellenga E., Swaanenburg J. C.M., Fidler V., Visser-van Brummen P. J., Kamps W. A. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia. Br. J. Haematol. 1999; 107(2)375–380, [INFOTRIEVE], [CSA], [CROSSREF]
  • Lehrnbecher Th., Venzon D., Haas d. M., Chanock S. J., Kuhl J. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia. Clin. Infect. Dis. 1999; 29(2)414–419, [INFOTRIEVE], [CSA]
  • Kern W. V., Heiss M., Steinbach G. Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy. Clin. Infect. Dis. 2001; 32(5)832–835, [INFOTRIEVE], [CSA], [CROSSREF]
  • Oude Nijhuis C. S.M., Kamps W. A., Daenen S. M.G.J., Gietema J. A., Graaf v.d. W. T.A., Groen H. J.M., Vellenga E., Fidler V., de Bont E. S.J.M. No antibiotics for selected febrile neutropenic cancer patients might be safe and feasible. Proc. Am. Soc. of Clin. Oncol. 2003; 22: 2961, [CSA]
  • Sonis S. T. Oral complications. Cancer Medicine, 4th ed., J. F. Holland, R. C. Bast, Jr, D. L. Morton, E. Frei, III, D. W. Kufe, R. R. Weichselbaum. Williams & Wilkins, Philadelphia 1997; 3255–3264
  • Pico J. L., Avila-Garavito A., Naccache P. Mucositis: its occurrence, consequences, and treatment in the oncology setting. Oncologist 1998; 3(6)446–451, [INFOTRIEVE], [CSA]
  • Woo S. B., Sonis S. T., Monopoli M. M., Sonis A. L. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 1993; 72(5)1612–1617, [INFOTRIEVE], [CSA], [CROSSREF]
  • Blijlevens N. M., Donnelly J. P., de Pauw B. E. Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant. 2000; 25(12)1269–1278, [INFOTRIEVE], [CSA], [CROSSREF]
  • Sonis S. T. The pathobiology of mucositis. Nature Reviews Cancer 2004; 4(4)277–284, [INFOTRIEVE], [CSA], [CROSSREF]
  • Kubesova H., Penka M., Kral Z., Adam Z., Vasova I., Tomiska M., Vorlicek J. Herpes Simplex Infection as possible etiology for febrile neutropenia and mucositis in patients treated for hematological malignancies. Acta Med. Austriaca 1998; 25: 2557–2560, [CSA]
  • Bergmann O. J., Mogensen S. C., Ellegaard J. Herpes simplex virus and intraoral ulcers in immunocompromised patients with haematologic malignancies. Eur. J. Clin. Microbiol. Infect. Dis. 1990; 9(3)184–190, [INFOTRIEVE], [CSA], [CROSSREF]
  • Rasoul-Rockenschaub S., Zielinski C. C., Muller C., Tichatschek E., Popow-Kraupp T., Kunz C. Viral reactivation as a cause of unexplained fever in patients with progressive metastatic breast cancer. Cancer Immunol. Immunother. 1990; 31(3)191–195, [INFOTRIEVE], [CSA], [CROSSREF]
  • Bone R. C., Balk R. A., Cerra F. B., Dellinger R. P., Fein A. M., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101(6)1644–1655, [INFOTRIEVE], [CSA]
  • Sonis S. T., Eilers J. P., Epstein J. B., LeVeque F. G., Liggett W. H., Jr, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer 1999; 85(10)2103–2113, [INFOTRIEVE], [CSA], [CROSSREF]
  • Oral complications of cancer therapies: diagnosis, prevention, and treatment. National Institutes of Health. Conn. Med. 1989; 53(10)595–601, [CSA]
  • Schonbohn H., Schuler M., Kolbe K., Peschel C., Huber C., Bemb W., Aulitzky W. E. Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia. Ann. Hematol. 1995; 71(4)161–168, [INFOTRIEVE], [CSA], [CROSSREF]
  • Bochud P. Y., Calandra T., Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am. J. Med. 1994; 97(3)256–264, [INFOTRIEVE], [CSA], [CROSSREF]
  • Ruescher T. J., Sodeifi A., Scrivani S. J., Kaban L. B., Sonis S. T. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 1998; 82(11)2275–2281, [INFOTRIEVE], [CSA], [CROSSREF]
  • Donnelly J. P., Muus P., Schattenberg A., de Witte T., Horrevorts A., de Pauw B. E. A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients. Bone Marrow Transplant. 1992; 9409–9413, [CSA]
  • Sonis S. T., Oster G., Fuchs H., Bellm L. A., Bradford, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J. Clin. Oncol. 2001; 19(8)2201–2205, [INFOTRIEVE], [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.